GNC Holdings, Inc. Reports Third Quarter 2019 Results


  • Net loss of $2.4 million for the third quarter of 2019; Adjusted net income of $3.1 million, an increase of $1.0 million compared with the third quarter of 2018

  • Domestic same store sales decreased 2.8% compared with the third quarter of 2018

  • U.S. and Canada segment achieved third consecutive quarter of year-over-year operating income growth

PITTSBURGH, Oct. 24, 2019 (GLOBE NEWSWIRE) -- GNC Holdings, Inc. (NYSE: GNC) (the “Company”) reported consolidated revenue of $499.1 million in the third quarter of 2019, compared with consolidated revenue of $580.2 million in the third quarter of 2018.  The decrease in revenue was primarily a result of the transfer of the Nutra manufacturing and China businesses to the newly formed joint ventures, the closure of company-owned stores under our store portfolio optimization strategy, U.S. and Canada negative same store sales of 2.8% and lower International franchise revenue.

Key Updates

  • U.S. and Canada segment drove 190 bps of incremental operating income margin compared with the third quarter of 2018, excluding the long-lived asset impairment charges in the prior year quarter and immaterial gains on refranchising in the current quarter and prior year quarter

  • E-Commerce revenues grew 12% compared with the third quarter of 2018 driven by increased conversion rates due to an improved site experience

  • In early October, formally launched GNC4U, our personalized, high quality supplement program that delivers customized vitamin packs monthly to a customer’s home

  • Company continues to evaluate debt refinancing alternatives and expects to complete the process in the fourth quarter of 2019

  • Cash provided by operating activities is $98 million; Year-to-date free cash flow(1) is $87 million and Adjusted EBITDA(2) is $166 million

  • Ended third quarter with $190 million in liquidity

For the third quarter of 2019, the Company reported net loss of $2.4 million compared with net loss of $8.6 million in the prior year quarter. Diluted loss per share was $0.09 in the current quarter compared with diluted loss per share of $0.10 in the prior year quarter. Excluding the expenses outlined in the table below, adjusted net income(3) was $3.1 million in the current quarter, compared with adjusted net income(3) of $2.1 million in the prior year quarter.  Adjusted diluted loss per share(3) was $0.02 in the current quarter compared with adjusted diluted earnings per share(3) ("EPS") of $0.02 in the prior year quarter.

Adjusted EBITDA(2), as defined and reconciled to net income in the table below, was $37.1 million, or 7.4% of revenue, in the current quarter compared with $50.1 million, or 8.6% of revenue, in the prior year quarter.

“In the third quarter, GNC continued to make strides stabilizing the US retail business driven by continued success with our store optimization and cost saving initiatives.  Additionally, as outlined on last quarter’s call, we made progress in addressing e-commerce opportunities and drove solid growth in the quarter,” said Ken Martindale, GNC’s Chairman and CEO.  “While we did face headwinds in our international business, we remain excited about the long-term growth opportunities abroad.”

 _____________________
(1) This Non-GAAP financial measure is reconciled to GAAP below, under the caption "Reconciliation of Net Cash Provided by Operating Activities to Free Cash Flow"
(2) This Non-GAAP financial measure is reconciled to GAAP below under the caption "Reconciliation of Net Income to Adjusted EBITDA"
(3) This Non-GAAP financial measure is reconciled to GAAP below under the caption "Reconciliation of Net Income and Diluted EPS to Adjusted Net Income and Adjusted EPS"

Segment Operating Performance

U.S. & Canada

Revenues in the U.S. and Canada segment decreased $31.8 million, or 6.7%, to $444.7 million for the three months ended September 30, 2019 compared with $476.5 million in the prior year quarter. E-commerce sales comprised 8.6% of U.S. and Canada revenue for the three months ended September 30, 2019 compared with 7.2% in the prior year quarter.

The decrease in revenue compared with the prior year quarter was largely due to the closure of company-owned stores under our store portfolio optimization strategy, which contributed a $14.8 million decrease in revenue, and negative same store sales of 2.8%, which resulted in a revenue decrease of $9.7 million. In domestic franchise locations, same store sales for the third quarter of 2019 decreased 0.8% over the prior year quarter.

Operating income increased $21.2 million to $32.7 million, or 7.4% of segment revenue, for the three months ended September 30, 2019 compared with $11.5 million, or 2.4% of segment revenue, for the same period in 2018. In the prior year quarter, we recorded long-lived asset impairment and other store closing charges totaling $14.6 million. Excluding the long-lived asset impairment charges in the prior year quarter and immaterial gains on refranchising in the current quarter and prior year quarter, operating income was $32.7 million, or 7.3% of segment revenue, in the current quarter, compared with $26.0 million, or 5.4% of segment revenue. The increase in operating income percentage was driven by lower occupancy expense, salaries and benefits.

International

Revenues in the International segment decreased $14.5 million, or 28.1%, to $36.9 million for the three months ended September 30, 2019 compared with $51.4 million in the prior year quarter. Revenue from our international franchisees decreased $9.1 million in the current quarter compared with the prior year quarter primarily due to lower sales in Hong Kong and other temporary challenges in Saudi Arabia and South Korea.  Revenue from China decreased by $5.1 million in the current quarter compared with the prior year quarter due to the transfer of the China business to the newly formed joint venture, effective February 13, 2019.

Operating income decreased $3.8 million to $12.7 million, or 34.3% of segment revenue, for the three months ended September 30, 2019 compared with $16.5 million, or 32.0% of segment revenue, for the same period in 2018.  The prior year quarter included China joint venture start-up costs of $1.0 million, of which $0.6 million related to costs incurred in the first six months of 2018 within corporate costs that was reclassified to International in the third quarter of 2018. Excluding the China joint venture start-up costs, operating income was $17.4 million, or 33.9% of segment revenue, for the three months ended September 30, 2018. The increase in operating income percentage compared to the prior year quarter was primarily a result of the transfer of the China business to the newly formed joint venture.

Manufacturing / Wholesale

Revenues in the Manufacturing / Wholesale segment, excluding intersegment sales, decreased $34.9 million, or 66.7%, to $17.4 million for the three months ended September 30, 2019 compared with $52.3 million in the prior year quarter primarily due to the transfer of the Nutra manufacturing business to the newly formed manufacturing joint venture with International Vitamin Corporation, effective March 1, 2019.

Operating income decreased $11.8 million to $5.1 million, or 29.0% of segment revenue, for the three months ended September 30, 2019 compared with $16.9 million, or 14.5% of segment revenue, in the prior year quarter.  Revenue decreased as a result of the transfer of the Nutra manufacturing business to the newly formed joined venture, however, operating income margins were positively impacted as the Manufacturing / Wholesale segment recognized profit margin that resulted from maintaining consistent pricing to what was charged to our other operating segments prior to the inception of the manufacturing joint venture, and recorded profit on intersegment sales associated with inventory produced prior to the transfer of the Nutra manufacturing business to the joint venture.

Year-to-Date Performance

For the first nine months of 2019, the Company reported consolidated revenue of $1,597.8 million, a decrease of $207.9 million compared with consolidated revenue of $1,805.7 million for the first nine months of 2018. The decrease in revenue during the first nine months of 2019 compared to the prior year period was largely due to the transfer of the Nutra manufacturing and China e-commerce businesses to the newly formed joint ventures, which resulted in a decrease in revenue of approximately $97 million, the closure of company-owned stores under our store portfolio optimization strategy, which resulted in a decrease in revenue of approximately $44 million, and negative same store sales of 3.0%, which resulted a decrease in revenue of approximately $33 million.

For the first nine months of 2019, the Company reported net loss of $1.6 million and diluted loss per share of $0.18 compared with net income of $10.9 million and diluted EPS of $0.13 for the first nine months of 2018. Excluding the expenses outlined in the reconciliation table below, adjusted EPS(3) was $0.30 and $0.47 in the first nine months of 2019 and 2018, respectively.

Cash Flow and Liquidity Metrics

For the nine months ended September 30, 2019, the Company generated net cash from operating activities of $97.6 million compared with $55.7 million for the nine months ended September 30, 2018. The increase was driven primarily by an increase in accounts payable as a result of the Company's cash management efforts as well as the establishment of payables associated with the manufacturing joint venture.

For the nine months ended September 30, 2019, the Company generated $86.7 million in free cash flow(1) compared with $42.3 million (1) for the nine months ended September 30, 2018. The Company defines free cash flow as cash provided by operating activities less capital expenditures. At September 30, 2019, the Company’s cash and cash equivalents were $121.9 million and debt was $858.6 million. No borrowings were outstanding on the Company's Revolving Credit Facility at the end of the third quarter of 2019.

The Company is reviewing a range of refinancing options, including discussions with financing sources in the United States and Asia, to further optimize the Company's capital structure and enhance its financial flexibility.  The Board has created a committee of independent directors to conduct this review process.  While there can be no assurances, the Company is pleased with its progress in reviewing refinancing options and expects to complete the process in the fourth quarter.

Conference Call

GNC has scheduled a live webcast to report its third quarter 2019 financial results on October 24, 2019 at 8:30 a.m. ET. To participate on the live call, listeners in North America may dial 1-888-254-3590 and international listeners may dial 1-323-994-2093.  In addition, a live webcast of the call will be available on www.gnc.com via the Investor Relations section under “About GNC.”  A replay of this webcast will be available through November 7, 2019.

About Us

GNC Holdings, Inc. (NYSE: GNC) is a leading global health and wellness brand that provides high quality science-based products and solutions consumers need to live mighty, live fit, live long and live well.

The brand touches consumers worldwide by providing its products and services through company-owned retail locations, domestic and international franchise locations, digital commerce and strong wholesale and retail partnerships across the globe.  GNC’s diversified, multi-channel business model has worldwide reach and a well-recognized, trusted brand.  By combining exceptional innovation, product development capabilities and an extensive global distribution network, GNC manages a best in class product portfolio. As of September 30, 2019, GNC had approximately 7,800 locations, of which approximately 5,700 retail locations are in the United States (including approximately 1,900 Rite Aid licensed store-within-a-store locations) and the remainder are locations in approximately 50 countries.

Forward-Looking Statements Involving Known and Unknown Risks and Uncertainties

This release contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 with respect to the Company’s financial condition, results of operations and business that is not historical information. Forward-looking statements can be identified by the use of terminology such as “subject to,” “believes,” “anticipates,” “plans,” “expects,” “intends,” “estimates,” “projects,” “may,” “will,” “should,” “can,” the negatives thereof, variations thereon and similar expressions, or by discussions regarding dividend, share repurchase plan, strategy and outlook. While GNC believes there is a reasonable basis for its expectations and beliefs, they are inherently uncertain. The Company may not realize its expectations and its beliefs may not prove correct. Many factors could affect future performance and cause actual results to differ materially from those matters expressed in or implied by forward-looking statements, including but not limited to competition; our ability execute on, or realize the expected benefit from the implementation of, our strategic initiatives; resources devoted to product innovation may not yield new products that achieve commercial success; difficulties with our vendors; failure to maintain and/or upgrade our information technology systems, including electronic payments systems; risks and costs associated with security breaches, data loss, credit card fraud and identity theft; risks associated with our international operations; impact of our current debt profile and obligations under our debt instruments; deployment of real estate strategy and significant lease obligation; successful development and maintenance of a relevant omni-channel experience for our customers; disruptions in our manufacturing system; unfavorable publicity or consumer perception of our products; any significant disruption to our distribution network, inventory management system, or to the timely receipt of inventory; issues with franchisees; material product liability claims, or product recalls; any increase in the price and shortage of supply of key raw materials; general economic conditions, including a prolonged weakness in the economy; compliance with new and existing laws and governmental regulations; failure to comply with FTC regulations; failure  to protect our brand name and intellectual property; potential impact of issuance of Series A Convertible Preferred Stock including dividend and repurchase obligations; the terms and features of our current Notes may have a negative impact on our liquidity, dilution or reported financial results; issues related to joint ventures; failure to attract or retain key employees; not being insured for a significant portion of our claims exposure; our use of derivative instruments for hedging purposes; impact of potential future impairment charges; our holding company structure; historic volatility of our common stock price; and the impact of natural disasters (whether or not caused by climate change), unusually adverse weather conditions, pandemic outbreaks, terrorist acts and global politics.

The Company undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise. Actual results could differ materially from those described or implied by such forward-looking statements. For a listing of factors that may materially affect such forward-looking statements, please refer to the Company’s Annual Report on Form 10-K for the year ended December 31, 2018.

Non-GAAP Measures

Management has included non-GAAP financial measures in this press release, including adjusted net income, adjusted EPS, adjusted EBITDA, adjusted as reflected in this release, and free cash flow, because it believes they represent an effective supplemental means by which to measure the Company’s operating performance.

Management believes that these measures are useful to investors as they enable the Company and its investors to evaluate and compare the Company’s results from operations in a more meaningful and consistent manner by excluding specific items which are not reflective of ongoing operating results and that can differ significantly from company to company depending on long-term strategic decisions regarding capital structure, the tax jurisdictions in which companies operate and capital investments.

However, these measures are not measurements of the Company’s performance under GAAP and should not be considered as alternatives to earnings per share, net income or any other performance measures derived in accordance with GAAP, or as an alternative to GAAP cash flow from operating activities, or as a measure of the Company’s profitability or liquidity.  For more information, see the attached reconciliations of non-GAAP financial measures.


GNC HOLDINGS, INC. AND SUBSIDIARIES
Consolidated Statements of Operations
(in thousands, except per share amounts)

 Three months ended September 30, Nine months ended September 30,
 2019 2018 2019 2018
 (unaudited)
Revenue$499,076  $580,185  $1,597,837  $1,805,662 
Cost of sales, including warehousing, distribution and occupancy336,448  395,483  1,038,374  1,206,351 
Gross profit162,628  184,702  559,463  599,311 
Selling, general, and administrative135,795  149,903  427,938  469,164 
Long-lived asset impairments  14,556    14,556 
Loss on net asset exchange for the formation of the joint ventures    21,293   
Other loss (income), net179  282  (622) 357 
Operating income26,654  19,961  110,854  115,234 
Interest expense, net24,456  35,732  82,376  90,448 
Gain on convertible debt repurchase    (3,214)  
Loss on forward contracts for the issuance of convertible preferred stock    16,787   
Loss on debt refinancing      16,740 
Income (loss) before income taxes2,198  (15,771) 14,905  8,046 
Income tax expense (benefit)5,733  (7,181) 20,719  (2,895)
(Loss) income before income from equity method investments(3,535) (8,590) (5,814) 10,941 
Income from equity method investments1,117    4,192   
Net (loss) income$(2,418) $(8,590) $(1,622) $10,941 
(Loss) earnings per share:       
Basic$(0.09) $(0.10) $(0.18) $0.13 
Diluted$(0.09) $(0.10) $(0.18) $0.13 
Weighted average common shares outstanding:       
Basic83,823  83,412  83,667  83,326 
Diluted83,823  83,412  83,667  83,431 


GNC HOLDINGS, INC. AND SUBSIDIARIES
Reconciliation of Net (Loss) Income and Diluted EPS to Adjusted Net Income and Adjusted EPS
(in thousands, except per share data)

 Three months ended September 30, Nine months ended September 30,
 2019 2018 2019 2018
 Net (Loss) Income Diluted EPS (1) Net (Loss) Income Diluted EPS Net (Loss) Income Diluted EPS (2) Net Income Diluted EPS
 (unaudited)
Reported$(2,418) $(0.09) $(8,590) $(0.10) $(1,622) $(0.18) $10,941  $0.13 
Loss on net asset exchange for the formation of the joint ventures        21,293  0.16     
Gain on convertible notes repurchase        (3,214) (0.02)    
Amortization of discount in connection with early debt payment        3,119  0.02     
Loss on forward contracts related to the issuance of convertible preferred stock        16,787  0.12     
Loss on debt refinancing             16,740  0.20 
Long-lived asset impairments    14,556  0.17      14,556  0.17 
Other (3)825  0.01  3,689  0.05  2,002  0.01  7,152  0.08 
Tax effect (4)4,675  0.06  (4,010) (0.06) 2,058  0.02  (6,721) (0.07)
Discrete tax benefit (5)    (3,583) (0.04)     (3,583) (0.04)
Adjusted$3,082  $(0.02) $2,062  $0.02  $40,423  $0.30  $39,085  $0.47 
                
Weighted average diluted common shares outstanding83,823    83,515    136,589   83,431  

Reconciliation of Net (Loss) Income to Adjusted EBITDA
(in thousands)

 Three months ended
September 30,
 Nine months ended
September 30,
 2019 2018 2019 2018
 (unaudited)
Net (loss) income$(2,418) $(8,590) $(1,622) $10,941 
Income tax expense5,733  (7,181) 20,719  (2,895)
Interest expense, net24,456  35,732  82,376  90,448 
Loss on debt refinancing      16,740 
Depreciation and amortization8,466  11,896  27,170  36,002 
Loss on net asset exchange for equity method investments    21,293   
Gain on convertible notes repurchase    (3,214)  
Loss on forward contracts related to the issuance of convertible preferred stock    16,787   
Long-lived asset impairments  14,556    14,556 
Other (3)825  3,689  2,002  7,152 
Adjusted EBITDA$37,062  $50,102  $165,511  $172,944 

(1) The Company applies the if-converted method to calculate dilution impact of the convertible senior notes and the convertible preferred stock. For reported and adjusted diluted EPS for the three months ended September 30, 2019, the underlying shares of the convertible preferred stock and the convertible senior notes are anti-dilutive. Therefore, the diluted EPS included a reduction to net (loss) income for the cumulative undeclared dividends of $5.0 million.

(2) For reported diluted EPS for the nine months ended September 30, 2019, the underlying shares of the convertible preferred stock and the convertible senior notes are anti-dilutive. Therefore, the reported diluted EPS included a reduction to net loss for the cumulative undeclared dividends of $13.7 million. For the adjusted EPS for the nine months ended September 30, 2019, the underlying shares of the convertible preferred stock is dilutive and the convertible senior notes are anti-dilutive. As a result of the difference in the calculation for reported diluted EPS and adjusted diluted EPS, amounts do not sum.

(3) The three months ended September 30, 2019 includes retention of $0.5 million, severance expense of $0.4 million, and immaterial refranchising gains. The three months ended September 30, 2018 included retention of $2.1 million, a legal-related charge of $1.3 million, long-lived asset impairments of $14.6 million, China joint venture start-up costs of $0.3 million and immaterial refranchising gains. The nine months ended September 30, 2019 included retention of $1.9 million, severance expense of $0.4 million and immaterial refranchising gains. The nine months ended September 30, 2018 included retention of $5.2 million, a legal related charge of $1.3 million, long-lived asset impairments of $14.6 million, China joint venture start-up costs of $1.0 million and immaterial refranchising gains. The retention expense recognized in 2019 and 2018 relates to an incentive program to retain senior executives and certain other key personnel who are critical to the execution and success of the Company's strategy.  The total amount awarded was approximately $10 million, of which approximately $1 million has been forfeited as of September 30, 2019, and which vests in four installments of 25% each on November 2018, February 2019, August 2019 and February 2020.

(4)  The Company generally utilizes a blended federal rate plus a net state rate that excludes the impact of certain state net operating losses, state credits and valuation allowance to calculate the impact of adjusted items.  In connection with the transfer of the Nutra manufacturing net assets to the newly formed manufacturing joint venture in the first quarter of 2019, the Company recorded a gain for tax purposes which was treated as ordinary and impacts the Company’s annual effective tax rate.  Therefore, for adjusted diluted EPS, the tax effect for the impact of the loss on net asset exchange for equity method investments related to the manufacturing joint venture transaction was adjusted consistent with the annual treatment for tax purposes.  For the three and nine months ended September 30, 2018,  the Company utilized an annual effective tax rate, adjusted to exclude discrete items and the tax impact of loss on debt financing.

(5)  Relates to discrete tax benefits associated with finalization of the Company's 2017 federal income tax return.


GNC HOLDINGS, INC. AND SUBSIDIARIES
U.S. Company-Owned Same Store Sales (including GNC.com)

 2019 2018
 Q1  3/31 Q2  6/30 Q3  9/30 Q1  3/31 Q2  6/30 Q3  9/30
Contribution to same store sales:           
Domestic retail same store sales(1.9)% (3.9)% (4.4)% (1.2)% (4.2)% (3.4)%
GNC.com contribution to same store sales0.3% (0.7)% 1.6% 1.7% 3.8% 1.3%
Total same store sales(1.6)% (4.6)% (2.8)% 0.5% (0.4)% (2.1)%


GNC HOLDINGS, INC. AND SUBSIDIARIES
Consolidated Balance Sheets
(in thousands)

 September 30, December 31,
 2019 2018
 (unaudited)
Current assets:   
Cash and cash equivalents$121,857  $67,224 
Receivables, net111,053  127,317 
Inventory394,763  465,572 
Forward contracts for the issuance of convertible preferred stock  88,942 
Prepaid and other current assets17,378  55,109 
Total current assets645,051  804,164 
Long-term assets:   
Goodwill79,041  140,764 
Brand name300,720  300,720 
Other intangible assets, net72,710  92,727 
Property, plant and equipment, net89,104  155,095 
Right-of-use assets362,774   
Equity method investments99,729   
Other long-term assets34,752  34,380 
Total long-term assets1,038,830  723,686 
Total assets$1,683,881  $1,527,850 
Current liabilities:   
Accounts payable$166,527  $148,782 
Current portion of long-term debt152,919  158,756 
Current portion of lease liabilities115,473   
Deferred revenue and other current liabilities97,169  120,169 
Total current liabilities532,088  427,707 
Long-term liabilities:   
Long-term debt705,667  993,566 
Deferred income taxes15,223  39,834 
Lease liabilities347,658   
Other long-term liabilities47,518  82,249 
Total long-term liabilities1,116,066  1,115,649 
Total liabilities1,648,154  1,543,356 
    
Mezzanine equity:   
Convertible preferred stock211,395  98,804 
    
Stockholders’ deficit:   
Common stock130  130 
Additional paid-in capital1,011,857  1,007,827 
Retained earnings552,095  613,637 
Treasury stock, at cost(1,725,349) (1,725,349)
Accumulated other comprehensive loss(14,401) (10,555)
Total stockholders’ deficit(175,668) (114,310)
Total liabilities, mezzanine equity and stockholders’ deficit$1,683,881  $1,527,850 


GNC HOLDINGS, INC. AND SUBSIDIARIES
Consolidated Statements of Cash Flows
(in thousands)

 Nine months ended September 30,
 2019 2018
Cash flows from operating activities:(unaudited)
Net (loss) income$(1,622) $10,941 
Adjustments to reconcile net income to net cash provided by operating activities:   
Depreciation and amortization expense27,170  36,002 
Income from equity method investments(4,192)  
Amortization of debt costs16,491  14,583 
Stock-based compensation4,343  5,102 
Long-lived asset impairments  14,556 
Loss on forward contracts related to the issuance of convertible preferred stock16,787   
Loss on net asset exchange for the formation of the joint ventures121,293   
Gain on convertible notes repurchase(3,214)  
Gains on refranchising(440) (276)
Loss on debt refinancing  16,740 
Third-party fees associated with refinancing  (16,322)
Distributions received from equity method investments791   
Changes in assets and liabilities(1):   
Increase in receivables(4,933) (6,080)
Decrease (increase) in inventory9,718  (5,794)
Increase in prepaid and other current assets(843) (6,552)
Increase in accounts payable48,795  6,860 
Decrease in deferred revenue and accrued liabilities(9,456) (10,565)
Decrease in net lease liabilities(25,382)  
Other operating activities2,332  (3,506)
Net cash provided by operating activities97,638  55,689 
    
Cash flows from investing activities:   
Capital expenditures(10,933) (13,355)
Refranchising proceeds, net of store acquisition costs2,062  1,916 
Proceeds from net asset exchange99,221   
Capital contribution to the newly formed joint ventures(13,079)  
Net cash provided by (used in) investing activities77,271  (11,439)
    
Cash flows from financing activities:   
Borrowings under revolving credit facility22,000  261,500 
Payments on revolving credit facility(22,000) (261,500)
Proceeds from the issuance of convertible preferred stock199,950   
Payments on Tranche B-1 Term Loan(147,312) (3,413)
Payments on Tranche B-2 Term Loan(123,774) (32,100)
Convertible notes repurchase(24,708)  
Original Issuance Discount and revolving credit facility fees(10,365) (35,235)
Fees associated with the issuance of convertible preferred stock(12,814) (3,443)
Minimum tax withholding requirements(233) (296)
Net cash used in financing activities(119,256) (74,487)
    
Effect of exchange rate changes on cash and cash equivalents(1,020) (416)
Net increase (decrease) in cash and cash equivalents54,633  (30,653)
Beginning balance, cash and cash equivalents67,224  64,001 
Ending balance, cash and cash equivalents$121,857  $33,348 

(1) Change in working capital amounts related to the transfer of net assets to the newly formed joint ventures are included in the caption "Loss on net asset exchange for the formation of joint ventures".


GNC HOLDINGS, INC. AND SUBSIDIARIES
Reconciliation of Net Cash Provided by Operating Activities to Free Cash Flow
(in thousands)

 Nine months ended  September 30,
 2019 2018
 (unaudited)
    
Net cash provided by operating activities$97,638  $55,689 
Capital expenditures(10,933) (13,355)
Free cash flow$86,705  $42,334 
    


GNC HOLDINGS, INC. AND SUBSIDIARIES
Segment Financial Data
 (in thousands)

 Three months ended September 30, Nine months ended  September 30,
 2019 2018 2019 2018
 (unaudited)
Revenue:       
U.S. and Canada$444,734  $476,519  $1,409,951  $1,506,250 
International36,940  51,407  117,311  140,107 
Manufacturing / Wholesale:       
Intersegment revenues  63,695  35,505  193,596 
Third-party17,402  52,259  70,575  159,305 
Subtotal Manufacturing / Wholesale17,402  115,954  106,080  352,901 
Total reportable segment revenues499,076  643,880  1,633,342  1,999,258 
Elimination of intersegment revenues  (63,695) (35,505) (193,596)
Total revenue$499,076  $580,185  $1,597,837  $1,805,662 
Operating income:       
U.S. and Canada$32,715  $11,466  $134,017  $100,559 
International12,653  16,468  40,972  46,624 
Manufacturing / Wholesale5,052  16,869  32,514  47,722 
Total reportable segment operating income50,420  44,803  207,503  194,905 
Corporate costs(23,766) (24,732) (75,106) (79,511)
Loss on net asset exchange for the formation of the joint ventures    (21,293)  
Other  (110) (250) (160)
Unallocated corporate costs, loss on net asset exchange and other(23,766) (24,842) (96,649) (79,671)
Total operating income$26,654  $19,961  $110,854  $115,234 


GNC HOLDINGS, INC. AND SUBSIDIARIES
Consolidated Store Count Activity

 Nine months ended September 30,
 2019 2018
U.S. & Canada   
Company-owned(1):   
Beginning of period balance3,206  3,423 
Openings21  18 
Acquired franchise locations(2)21  20 
Franchise conversions(3)(5) (4)
Closings(244) (174)
End of period balance2,999  3,283 
Domestic Franchise:   
Beginning of period balance1,037  1,099 
Openings6  10 
Acquired franchise locations(2)(21) (20)
Franchise conversions(3)5  4 
Closings(40) (45)
End of period balance987  1,048 
International(4):   
Beginning of period balance1,957  2,015 
Openings63  42 
Closings(94) (89)
  China locations contributed to the China joint venture(5)  
End of period balance1,921  1,968 
Store-within-a-store (Rite Aid):   
Beginning of period balance2,183  2,418 
Openings31  42 
Closings(342) (218)
End of period balance1,872  2,242 
Total Locations7,779  8,541 

_______________________________________________________________________________

(1) Includes Canada.

(2) Stores that were acquired from franchisees and subsequently converted into company-owned store locations.

(3) Company-owned store locations sold to franchisees.

(4) Includes franchise locations in approximately 50 countries (including distribution centers where sales are made) and company-owned locations in Ireland. Prior year also includes company-owned locations in China.

Contacts:
Investors:   Matt Milanovich, VP- Investor Relations & Treasury, (412) 402-7260; or
                  John Mills, Partner - ICR, (646) 277-1254

SOURCE:  GNC Holdings, Inc.

Web site:   http://www.gnc.com